Sign in

Ihsan Essaid

Chief Financial Officer at QXO
Executive

About Ihsan Essaid

Chief Financial Officer of QXO since July 15, 2024, following a senior investment banking career as Global Head of M&A at Barclays and earlier roles at Credit Suisse and Perella Weinberg Partners . Under Essaid’s finance leadership during 2025 integration of Beacon Roofing Supply, QXO reported net sales of $1.91B and Adjusted EBITDA of $204.6M in Q2, and net sales of $2.73B and Adjusted EBITDA of $302M in Q3, reflecting rapid scale-up and transformation initiatives post-acquisition . Company TSR context from the pay-versus-performance disclosure shows the $100 investment value series used for compensation alignment and benchmarking, with 2024 TSR value reported at $56.12 (pre/post transaction context) .

Past Roles

OrganizationRoleYearsStrategic Impact
BarclaysGlobal Head of M&ASenior M&A leadership; experience structuring large, complex transactions aligned with QXO’s acquisition-led strategy
Credit SuisseSenior M&A rolesExecution of strategic M&A; supports value creation via disciplined dealmaking and integration
Perella Weinberg PartnersSenior M&A rolesAdvisory on transformative deals; enhances QXO’s inorganic growth capabilities

External Roles

  • No public company directorships disclosed for Essaid .

Fixed Compensation

Item2024Notes
Salary (earned)$415,384Partial-year employment; joined July 15, 2024
Target bonus %125% of base salarySet in employment agreement; 2024 bonus paid in full at target (not pro-rated)
Bonus paid (incl. sign-on)$4,125,000Includes $3,000,000 sign-on bonus with 2-year repayment clawback if certain termination conditions occur

Compensation escalation schedule tied to revenue run-rate (effective each calendar year; increases only):

Annualized Revenue Run Rate BandBase Salary ($)Target Bonus (% of Salary)Target Bonus ($)
$5B–$10B1,100,000140%1,540,000
$10B–$20B1,185,000155%1,836,750
$20B–$30B1,425,000190%2,707,500
>$30B1,615,000190%3,068,500

Performance Compensation

Equity awards granted July 30, 2024 (intended as a multi-year package; no recurring annual grants during vesting term):

Award TypeGrant SizeKey Terms
RSUs847,500Time-based vesting; post-vesting transfer restriction until 12/31/2029 (except change in control or death)
PSUs (Target)1,137,500Relative TSR vs S&P 500; annual tranches plus a cumulative cliff tranche through 12/31/2028; transfer restriction until 12/31/2029

RSU vesting schedule (annual tranches):

20252026202720282029
15% 17.5% 17.5% 25% 25%

PSU performance metric and payout grid (Relative TSR vs S&P 500):

Percentile PositionPayout vs Target
Below 55th0%
55th100%
65th150%
75th175%
80th200%
90th225%

PSU performance periods:

  • Annual tranches measured each year (first determination after 12/31/2025) and a 50% cumulative long-term tranche measured on 12/31/2028; payout subject to relative TSR ranking per grid above .

Equity Ownership & Alignment

ItemValueDetail
Beneficial ownership (common)109,410 shares<1% of outstanding; as of record date March 20, 2025
Unvested RSUs847,500Outstanding at 12/31/2024
Unvested PSUs (Target)1,137,500Outstanding at 12/31/2024
OptionsNone disclosedCompany does not currently grant options
Holding/transfer restrictionsThrough 12/31/2029Post-vesting shares from RSUs/PSUs restricted from transfer (except change in control or death)
Hedging/pledgingNot disclosedSecurities Trading Policy referenced; specific hedging/pledging terms not disclosed in proxy

Stock ownership guidelines:

  • Formal multiple-of-salary guidelines not disclosed; long holding periods and transfer restrictions serve as alignment mechanism .

Employment Terms

TermProvisionNotes
Start dateJuly 15, 2024CFO appointment and agreement effective on employment commencement
Severance (involuntary, no cause / good reason)12 months base salary; prorated target bonus for year of termination; 6 months healthcareIf termination on/before 12/31/2026, make-whole cash equal to $3M minus vested equity value as of termination
Change-of-control termination (within 2 years)2× (base salary + target bonus); prorated target bonus; 12 months healthcareFull vesting of RSUs and PSUs; PSUs generally vest based on target or actual performance through change in control; 280G cutback if net-benefit to executive
Equity vesting on qualifying terminationPro-rata vesting of next RSU tranche; pro-rata PSU vesting (generally at target) for in-period annual tranche and cliff trancheDeath triggers full vesting at specified performance levels
Non-compete12 months post-employment; company may extend one additional year with monthly payments equal to 1/12 of target total annual cash compensationEmployee/customer non-solicit (2 years); confidentiality and non-disparagement obligations
ClawbackAccounting restatement recovery of incentive-based compensation (3-year lookback)Company-wide policy per SEC rules

Performance & Track Record (Company context during Essaid’s CFO tenure)

MetricQ2 2025Q3 2025
Net sales ($MM)1,906.4 2,728.3
Adjusted EBITDA ($MM)204.6 302.0

Notes:

  • Q2 results include legacy Beacon operations only from April 29, 2025 to June 30, 2025 following close of the Beacon acquisition .
  • Financing actions in Q2 included ~$4.9B debt raised and ~$4.8B equity/mandatory converts; net debt ~$1.2B at quarter-end .

Investment Implications

  • Strong pay-for-performance design: High share count PSUs tied to demanding relative TSR thresholds (no payout below 55th percentile; max at 90th percentile), aligning upside with shareholder returns and reducing windfall risk .
  • Retention mechanics: Multi-year RSU/PSU vesting with post-vesting transfer restrictions through 12/31/2029 and non-compete/non-solicit covenants materially limit near-term selling pressure and reinforce continuity during integration and transformation .
  • Cash protection and early termination risk: Make-whole protection up to $3M if terminated before 12/31/2026 offsets forfeited incentives and mitigates early departure risk, while standard severance (12 months) and double-trigger change-in-control (2× cash + full vesting) are market-consistent; 280G cutback avoids excise tax inefficiency .
  • Ownership alignment: Direct share ownership (<1%) is modest, but significant unvested RSUs/PSUs and long holding requirements provide substantial economic exposure to long-term value creation and relative TSR performance .
  • Governance safeguards: SOX certifications and a clawback policy on incentive compensation tied to financial reporting promote control rigor and mitigate restatement-linked compensation risk .